Lv1
80 积分 2024-01-11 加入
Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia
6小时前
待确认
Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia
6小时前
已关闭
Acute Myeloid Leukemia - Update 2022
9小时前
已关闭
Real-world tolerability of venetoclax-based maintenance therapy with azole antifungal prophylaxis for acute myeloid leukemia in remission
10小时前
已完结
Maintenance therapy for acute myeloid leukemia: sustaining the pursuit for sustained remission
11小时前
已完结
Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse
11小时前
已完结
Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial
12小时前
已完结
Maintenance Therapy in Acute Myeloid Leukemia
13小时前
已完结
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
1年前
已完结
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study
1年前
已完结
皖公网安备34019202002308
